About This Digest

What Iron Peptide Innovations is

Iron Peptide Innovations maps the published research on two peptides studied for recovery and tissue repair: BPC-157 and TB-500, with TB-500 as the lead. Its purpose is to make a scattered and frequently overstated literature legible — to tell a reader, in plain language and with citations, what each compound was actually studied for, in which species, and how far that evidence reaches.

The organizing idea is complementarity: BPC-157 and TB-500 approach repair from different directions — blood-vessel growth and cell migration — so reading them together gives a fuller picture than either alone. Each compound has its own page; a comparison page lines them up side by side; and a single shared references list gathers every source across both.

How it is compiled

Three principles govern what lands on this site.

First, every line is anchored to the peer-reviewed literature. Each research claim carries a numbered citation — PubMed-indexed journal articles and reviews, with DOIs and PubMed links — gathered on the references page. Where a finding comes from a review rather than a primary study, the review is cited as such.

Second, evidence is reported at its true strength. Doses appear as they were studied — "studied at 2 mg/kg in rats," say — never scaled to humans or offered as a recommendation. Where the evidence is preclinical, single-lab, or rests on a parent molecule rather than the marketed compound, the page states it outright. That candor is the point, not an afterthought.

Third, the pages cross-reference each other. Because themes — angiogenesis, actin and migration — recur across both compounds, the pages link to one another and to the comparison so a reader can trace a mechanism from one peptide to the next.

What it is not

Iron Peptide Innovations sells nothing, treats no one, and gives no medical advice. It does not supply, source, or broker any peptide or research chemical, and it holds no affiliate or referral tie to any vendor. No clinician staffs it; it diagnoses no condition and prescribes nothing. It recommends no dose, schedule, or route for any person, and it never dresses an animal-study dose up as something a human should take.

The peptides discussed here are research compounds. Neither is an approved medicine; both are explicitly prohibited in sport. Readers interested in any condition described in the underlying research should consult a licensed clinician working with regulated, evidence-based options. What this site offers is a plain, accurate map of the literature — nothing more, and nothing it pretends to be.